AG真人官方

The Charles Schwab Corporation insider reported a planned sale of shares under a Rule 10b5-1 plan. On 09/02/2025 the reporting person sold 3,205 shares of SCHW at a weighted average price of $95.2033 per share, with execution prices reported between $95.04 and $95.29. The Form 4 lists the reporting person as MD, Chief Banking Officer and indicates continued indirect beneficial ownership of 37,983.1078 shares held by a trust. The filing notes the sales were made pursuant to a 10b5-1 plan adopted on November 15, 2024, and the Form 4 was signed by an attorney-in-fact on 09/03/2025.

Jonathan S. Beatty, MD, Head of Advisor Services at The Charles Schwab Corporation (SCHW), reported option exercise and related sales in late August 2025. On 08/27/2025 he sold 3,296 shares at $97.18, leaving 11,923 shares reported as beneficially owned indirectly via a trust. On 08/28/2025 he exercised a nonqualified stock option with exercise price $46.39 for 6,144 shares, and those 6,144 shares were contributed to a trust per the form. The same day he sold 6,144 shares under a Rule 10b5-1 trading plan (adopted Feb 28, 2024) at a weighted average sale price of $96.8113. The option referenced was granted under the company鈥檚 2013 Stock Incentive Plan and vested in four equal annual installments.

Morgan Peter J. III, General Counsel of The Charles Schwab Corporation (SCHW), reported option exercises and a sale on 08/27/2025. The filing shows exercises of nonqualified stock options at strike prices of $46.39 (2,203 shares) and $64.10 (47,813 shares) that converted into 50,016 shares of common stock. Those 50,016 shares were then reported sold in multiple trades at a weighted average price of $97.0004, leaving the reporting person with 0 shares directly owned. The form also discloses indirect holdings of 150.468 (ESOP) and 451 (ESPP) in the issuer鈥檚 stock per plan statements. The filer notes the option grants were under the 2013 Stock Incentive Plan with standard vesting and that sale prices ranged from $96.895 to $97.09.

Charles R. Schwab, identified as Co-Chairman and a director of The Charles Schwab Corporation (SCHW), reported sales of common stock on 08/26/2025 and 08/27/2025. The Form 4 shows a sale of 136,500 shares on 08/26/2025 at a weighted average price of $96.666 and a sale of 136,500 shares on 08/27/2025 at a weighted average price of $97.044. Beneficial ownership lines reported after the transactions list 56,467,949 shares and 56,331,449 shares, respectively, held indirectly by trusts, plus additional indirect holdings described as 9,509,797.33 shares by spouse as trustee, 30,641,981 by a limited partnership, and 44,025 by 188 Corp. The form is signed by attorney-in-fact P. Blake Allen on 08/28/2025.

The Charles Schwab Corporation (SCHW) Form 144 notifies the planned sale of 13,216 common shares on 08/28/2025 through The Charles Schwab Corporation as broker on the NYSE, with an aggregate market value of $1,309,865.00. The filing states these shares were acquired on 08/28/2025 via various stock option exercises and sales, and payment was completed on that date. The filer previously sold 3,296 shares on 08/27/2025 for $320,305.00. Outstanding shares are listed as 1,815,219,300, showing the planned sale represents a de minimis fraction of total shares.

The filing reports that Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), sold 13,542 shares of SCHW common stock on 08/25/2025 in multiple trades at weighted average price $96.0569 per share. The report lists post-transaction beneficial ownership across several accounts: 1,463,656.6599 shares indirectly held by a trust, 460,114 shares indirectly held by spouse as trustee, 2,798 shares indirectly held by an LLC, and 9,624 shares directly held. The form was signed by attorney-in-fact P. Blake Allen on 08/27/2025. The filer states availability to provide detailed trade-level information on request.

Form 144 filing for The Charles Schwab Corporation (SCHW) reports a proposed sale of 3,296 common shares by the reporting person, acquired as restricted stock units on 03/01/2023 (and noted RSUs also from 03/01/2024). The filing lists an aggregate market value of $320,305 for the shares and shows approximately 1,815,219,300 shares outstanding for the issuer. The broker is listed as The Charles Schwab Corporation, Westlake TX and the approximate sale date is 08/27/2025 on the NYSE. The filer also disclosed a recent sale on 05/30/2025 of 2,850 shares for gross proceeds of $249,572. The signer affirms they are not aware of any material nonpublic information about the issuer.

The filing notifies a proposed sale of 50,016 shares of The Charles Schwab Corporation common stock with an aggregate market value of $4,852,552.00. The shares are scheduled for sale on the NYSE on 08/27/2025. The filing shows the shares were acquired the same day, 08/27/2025, via a stock option granted by the issuer and paid on that date. No other sales by the reporting person were reported in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Form 144 notice filed for The Charles Schwab Corporation (SCHW) documents proposed and completed sales of common stock by Charles R. Schwab. The filing shows a proposed sale of 136,500 shares (approximate aggregate market value $13,254,150) on 08/27/2025 to be executed on the NYSE. Acquisition details show these shares were acquired in a leveraged buyout on 03/31/1987. The filing also reports three sales by Charles R. Schwab in the prior three months: 22,721 shares (08/07/2025, $2,181,610), 133,153 shares (08/08/2025, $12,888,080), and 136,500 shares (08/26/2025, $13,194,903). The filer certifies no undisclosed material adverse information is known.